| Date | Time | Source | Headline | Symbol | Company |
| 10/05/2023 | 8:00AM | GlobeNewswire Inc. | Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023 | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 10/02/2023 | 7:33AM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/26/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:23PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:21PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:21PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:18PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:15PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:13PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 1:12PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:59AM | Edgar (US Regulatory) | Form SC 13E3/A - Going private transaction by certain issuers: [Amend] | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:42AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:39AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:37AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:32AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:28AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:26AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:24AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:21AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:18AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:16AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:14AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:12AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 09/21/2023 | 10:10AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |